Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.
Journal Information
Full Title: J Hematol Oncol
Abbreviation: J Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationAll authors have read and approved the final manuscript. Competing interestsThe authors declared that they have no competing interests. Competing interests The authors declared that they have no competing interests."
"Funding This work was supported by Guangdong Basic and Applied Basic Research Foundation (No. 2019B030302012), National Key Research and Development Project (No. 2020YFA0509400, and 2020YFC2002705), and National Natural Science Foundation of China (No. 81821002, 81790251, 82102738, 82103168, and 82003098)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025